Amanote Research
Register
Sign In
Cyclophosphamide and Tamoxifen as Adjuvant Therapies in the Management of Breast Cancer
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1988.137
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 1, 1988
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer
New England Journal of Medicine
Medicine
PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of Adjuvant Therapies for Breast Cancer in Iran
International Journal of Technology Assessment in Health Care
Health Policy
Granulosa Cell Tumor of the Ovary and Antecedent of Adjuvant Tamoxifen Use for Breast Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study
PLoS ONE
Multidisciplinary
Metformin as an Adjuvant in Breast Cancer Treatment
SAGE Open Medicine
Medicine
Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil
Revista da Associacao Medica Brasileira
Medicine
Bisphosphonates as Adjuvant Therapy for Breast Cancer
Women's Health
Medicine
The Relationship Between the CYP2D6 Polymorphisms and Tamoxifen Efficacy in Adjuvant Endocrine Therapy of Breast Cancer Patients in Chinese Han Population
International Journal of Cancer
Cancer Research
Oncology
